Compounds > mevalonic acid

mevalonic acid and Graft-Versus-Host Disease

mevalonic acid has been researched along with Graft-Versus-Host Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, J; Kambham, N; Negrin, RS; Steinman, L; Youssef, S; Zeiser, R1
Abinun, M; Arkwright, PD; Cant, AJ1

Other Studies

2 other study(ies) available for mevalonic acid and Graft-Versus-Host Disease

ArticleYear
Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity.
    Blood, 2007, Dec-15, Volume: 110, Issue:13

    Topics: Adoptive Transfer; Animals; Antigen Presentation; Atorvastatin; Chemoprevention; Cytokines; Graft vs Host Disease; Graft vs Leukemia Effect; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Mice, Knockout; Premedication; Pyrroles; Signal Transduction; STAT6 Transcription Factor; T-Lymphocytes; Th2 Cells

2007
Mevalonic aciduria cured by bone marrow transplantation.
    The New England journal of medicine, 2007, 09-27, Volume: 357, Issue:13

    Topics: Bone Marrow Transplantation; Child; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Metabolism, Inborn Errors; Mevalonic Acid; Transplantation, Homologous

2007